Research Topic: aspergillosis

COVID-19-associated Pulmonary Aspergillosis in Mechanically Ventilated Patients at 7 US Hospitals: Epidemiology and Estimated Likelihood of Invasive Pulmonary Aspergillosis—Results of the Prospective MSG-017 Study

mycolabadmin

A fungal infection caused by Aspergillus commonly occurs in COVID-19 patients on ventilators, affecting about 7% of cases. The study found that having this infection was linked to high death rates, but it was unclear whether the fungal infection itself or the severe COVID-19 caused the deaths. Single positive test results for the fungus are not reliable for diagnosis, and antifungal drugs did not improve survival rates.

Read More »

Genome sequences of Aspergillus fumigatus strains isolated from wildfowl in Southern Ontario, Canada

mycolabadmin

Researchers sequenced the genomes of four Aspergillus fumigatus fungi isolated from infected birds (an osprey, peregrine falcon, and two hawks) brought to wildlife rehabilitation centers in Ontario. This fungus causes a serious infection called aspergillosis that damages the lungs and air sacs of birds. The genetic information from these four strains is now publicly available for scientists studying how this fungus infects birds and how it resists antifungal treatments.

Read More »

Identification of Non-fumigatus Aspergillus Species in Clinical Samples from Southern California

mycolabadmin

Researchers in Southern California studied fungal infections caused by Aspergillus, a common mold that can infect humans. They found that species other than the traditionally dangerous A. fumigatus are now being detected more frequently in patient samples, particularly from skin and respiratory infections. These non-fumigatus species showed interesting seasonal patterns and some may be resistant to standard antifungal treatments, suggesting doctors may need to adjust their treatment strategies.

Read More »

Mixed Infection With Aspergillosis and Actinomycosis in the Maxillary Sinus: A Case Report

mycolabadmin

A 74-year-old woman had a purulent nasal discharge for 1.5 years caused by two different infections occurring simultaneously in her maxillary sinus: aspergillosis (a fungal infection) and actinomycosis (a bacterial infection). Imaging initially suggested only a fungal ball, but pathological examination revealed both organisms were present. The patient was successfully treated with surgical removal of the infected material followed by antibiotic therapy.

Read More »

Breaking the mould: challenging the status quo of clinical trial response definitions for invasive fungal diseases—a debate

mycolabadmin

Doctors and researchers use standard definitions to determine if antifungal treatments work in clinical trials. This debate examines whether the standards created in 2008 are still appropriate today. Key concerns include whether stable disease should always count as treatment failure, how to handle deaths from other causes, and whether newer testing methods should be incorporated. The expert panel concluded these definitions need updating to reflect modern treatment options and patient needs.

Read More »

Identification of a fungal antibacterial endopeptidase that cleaves peptidoglycan

mycolabadmin

Scientists discovered a new antibacterial protein called CwhA produced by the fungus Aspergillus fumigatus that acts like molecular scissors, cutting apart the cell walls of harmful bacteria like Staphylococcus aureus. This protein is produced by the fungus when it encounters bacteria in the lungs during infection and helps the fungus fight off bacterial competitors. When CwhA cuts up bacterial cell walls, it creates fragments that alert the immune system, potentially boosting the body’s defense response against infection.

Read More »

Usefulness of combining computed tomography and air sac fluid examination to rule out aspergillosis: case study in two gentoo penguins (Pygoscelis papua) with respiratory clinical signs

mycolabadmin

Two penguins at an aquarium showed respiratory problems and were suspected of having a serious fungal infection called aspergillosis. Doctors used CT scans to identify fluid in their air sacs and collected samples for testing. The tests showed the penguins did not have the fungal infection, so they did not need antifungal medications. Both penguins recovered naturally, demonstrating that combining imaging with fluid analysis can help identify the real cause of respiratory problems and avoid unnecessary medication.

Read More »
Scroll to Top